Sensus Healthcare is dedicated to improving the lives of men and women who suffer from skin cancer. We believe every patient deserves a choice. It’s the reason we offer a painless, safe and highly effective non-surgical skin cancer treatment that is an alternative to surgery—Superficial Radiotherapy using the SRT-100™.
Today, nearly five million people in the United States are treated for skin cancer, with four million new cases of basal and squamous cell (non-melanoma) skin cancer diagnosed each year. Treatment often involves invasive incisions that damage healthy tissue, painful healing, lengthy recovery and unsightly scarring that takes an emotional toll on patients. Sensus Healthcare is changing all that.
Leveraging clinically-proven technology that has been used for more than 50 years, the innovative SRT-100™ delivers a precise, calibrated dose of Superficial Radiotherapy that only goes skin deep. This low-dose of radiotherapy safely destroys non-melanoma skin cancer cells. Performed right in the doctor’s office, Superficial Radiotherapy with the SRT-100™ delivers optimum results without the negative side effects of invasive treatments. It is ideal for patients with existing medical conditions that make surgery a serious health risk.
Sensus Healthcare is dedicated to improving the lives of men and women who suffer from skin cancer. We believe every patient deserves a choice. It’s the reason we offer a painless, safe and highly effective non-surgical skin cancer treatment that is an alternative to surgery—Superficial Radiotherapy using the SRT-100™.
Today, nearly five million people in the United States are treated for skin cancer, with four million new cases of basal and squamous cell (non-melanoma) skin cancer diagnosed each year. Treatment often involves invasive incisions that damage healthy tissue, painful healing, lengthy recovery and unsightly scarring that takes an emotional toll on patients. Sensus Healthcare is changing all that
